漢田生技股份有限公司 Approved
最後更新時間 2025/05/18 , 02:43 AM
最後更新時間 2025/05/18 , 02:43 AM
負責人
Li,Yu-Lin
統一編號
28814153
成立日期
2007/10/22
資本額
NT$600,000,000
實收資本額
NT$276,232,630
股票代號
1294
電話
04-8383151
地址
No. 101, Gongye Rd., Xixi Vil., Xihu Township, Changhua County, 514, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Li,Yu-Lin Chairman 3.34%
Xie,Qing-Long Independent Director 0.00%
Wang,Yu-Qi Independent Director 0.00%
Zhu,Jian-Cheng Independent Director 0.00%
Ceng,Qing-Ying Independent Director 0.00%
Yang,Mei-Juan Director 14.48% HAN SHUO INVESTMENT CO., LTD.
Hong,Shang-Wen Director 1.98%
Chen,Jian-Hong Director 1.12%
Chen,Chong-Gui Director 0.92%
營業項目
  • Manufacture of health supplements(089800)
  • Wholesale of Other Food(454920)
  • Retail Sale via Mail Order Houses or via Internet(487199)
  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760912)
  • 公司歷程
  • Change Capital to 600,000,000
    2024/05/16
  • Change Capital to 300,000,000
    2020/10/23
  • Change Capital to 150,000,000
    2019/07/10
  • Change Capital to 80,000,000
    2013/11/13
  • Change Capital to 25,000,000
    2013/07/15
  • Change Capital to 22,300,000
    2012/10/04
  • Change Capital to 19,300,000
    2012/04/06
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 174,677 595,387 625,141
    Operating cost 109,414 350,186 344,289
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 65,263 245,201 280,852
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 65,263 245,201 280,852
    Operating expenses 23,544 84,424 95,146
    Other gain (loss), net - - -
    Operating profit (loss) 41,719 160,777 185,706
    Non-operating income and expenses -211 -3,141 -1,137
    Net profit (loss) before tax 41,508 157,636 184,569
    Income tax expense (benefits) 9,350 32,984 37,036
    Net profit (loss) of ongoing business for the current period 32,158 124,652 147,533
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 32,158 124,652 147,533
    Other comprehensive profit (loss), net - - -
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 32,158 124,652 147,533
    Net profit (loss) attributable to owners of parent company 32,156 124,843 148,118
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests 2 -191 -585
    Comprehensive profit (loss) attributable to owners of parent company 32,156 124,843 148,118
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 2 -191 -585
    Basic earnings per share (yuan) 1 4 7
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 29,808 68,580 191,906
    Net cash inflows (outflows) from investing activities -5,644 -21,589 -295,629
    Net cash inflow (outflow) from financing activities -42,673 189,653 195,827
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 35 15 -54
    Increase (decrease) in cash and cash equivalents in the current period -18,474 236,659 92,050
    Beginning balance of cash and cash equivalents 382,423 167,090 75,040
    Ending balance of cash and cash equivalents 363,949 403,749 167,090
    項目 2025 2024 2023
    Current asset 567,733 605,793 339,911
    Non-current asset 581,008 579,669 591,032
    Total asset 1,148,741 1,185,462 930,943
    Current liability 231,546 161,262 224,338
    Non-current liability 92,295 234,159 305,224
    Total liability 323,841 395,421 529,562
    share capital 276,233 276,008 193,669
    Equity - secruity token - - -
    capital reserve 296,272 296,202 36,875
    retained earning 277,717 214,730 167,545
    Other equity - - -
    Treasury stock -28,361 - -
    Total equity attributable to owners of parent company 821,861 786,940 398,089
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 3,039 3,101 3,292
    Total Equity 824,900 790,041 401,381
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 300,000 0 0
    Net asset value per share 30 28 20
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • Lulubaby
  • BW設計圖
  • Babylulu
  • 設計圖
  • 漢田生技
  • 漢一苑
  • 1定要美麗商標設計圖
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Compensation for damage, etc.
    2017
  • Cancellation of ownership transfer registration, etc.
    2015
  • Payment order
    2020
  • Stop execution
    2016
  • Promissory note ruling
    2020
  • Debtor objection appeal
    2016
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。